Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life.
We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and...
Avista's mission is to develop innovative gene therapies for retinal diseases, including rare, inherited conditions that have a profound impact on patients' quality of life.
We leverage our computationally guided scAAVengr platform to generate and validate a toolkit of proprietary AAV vectors that overcome the most significant obstacles to effective gene therapies, including cell-type specific delivery, reduced dosages, and efficient expression, using a minimally invasive intravitreal approach.
Our quantitative, in vivo-based approach and clinical ophthalmology expertise allow us to rapidly translate new gene therapies to the clinic.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.